Evidence map›Paper›PMID 27679440›Full record

ArticlePlant foods for human nutrition (Dordrecht, Netherlands)2016

Antioxidant and Anticancer Activities of Walnut (Juglans regia L.) Protein Hydrolysates Using Different Proteases.

Raheleh Jahanbani, S Mahmood Ghaffari, Maryam Salami, Kourosh Vahdati, Houri Sepehri, Nazanin Namazi Sarvestani, Nader Sheibani, Ali Akbar Moosavi-Movahedi

Open access · greenAbstract read
In one paragraph

Article in Plant foods for human nutrition (Dordrecht, Netherlands), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 125 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Nutritional Advantages of Walnut (Food science & nutrition · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Neuroprotective effects of walnutIranian journal of basic medical sciences · 2024
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Raheleh JahanbaniInstitute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
S Mahmood GhaffariInstitute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Maryam SalamiDepartment of Food Science and Engineering, University College of Agriculture & Natural Resources, University of Tehran, Karaj, Iran.
Kourosh VahdatiDepartment of Horticulture, College of Aburaihan, University of Tehran, Pakdasht, Tehran, Iran.
Houri SepehriAnimal Biology Department, School of Biology, College of Sciences, University of Tehran, Tehran, Iran.
Nazanin Namazi SarvestaniDepartments of Ophthalmology and Visual Sciences, and Biomedical Engineering, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Nader SheibaniAnimal Biology Department, School of Biology, College of Sciences, University of Tehran, Tehran, Iran.
Ali Akbar Moosavi-MovahediInstitute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran. moosavi@ut.ac.ir.
University of Tehran · IR

Funding

Novel Antiangiogenic Peptides for Treatment of Exudative AMDR24EY022883 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI SHEIBANI, NADER · 2013 to 2017
$6.2M
NEI NIH HHS R24 EY022883
6 · The paper itself

Abstract

Walnut (Juglans regia L.) contains approximately 20-25 % protein with abundant essential amino acids. The enzymatic hydrolysate of Persian walnut (Chandler) seed proteins was prepared by incubation with three different proteases, including pancreatic chymotrypsin and trypsin, and a microbial enzyme proteinase K. The hydrolysates were found to possess excellent antioxidant capacities. The peptide fractions scavenged the 2, 2'-anizo-bis-(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) free radicals and inhibited the activity of reactive oxygen species. Walnut protein hydrolysates were also tested, for the first time, against the viability of human breast (MDA-MB231) and colon (HT-29) cancer cell lines. MTT, [3-(4, 5dimethylthiazolyl)-2,5-diphenyl-tetrazolium bromide], assay was used to assess in vitro cancer cell viability upon treatment with the peptide fractions. The peptide fractions showed cell growth inhibition of 63 ± 1.73 % for breast cancer and 51 ± 1.45 % for colon cancer cells. Thus, a direct correlation between antioxidant and anticancer activities of walnut peptide fractions exists and supports their potential therapeutic benefit.

Indexed as

Antineoplastic AgentsAntioxidantsCell Line, TumorCell SurvivalHT29 CellsHumansJuglansNutsPeptide HydrolasesPlant ProteinsProtein HydrolysatesReactive Oxygen SpeciesAntineoplastic AgentsAntioxidantsPeptide HydrolasesPlant ProteinsProtein HydrolysatesReactive Oxygen SpeciesAnticancerAntioxidantBioactive peptidesProteaseWalnut proteins

Identifiers

PMID27679440
PMCPMC5223242
OpenAlexW2525485701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.